Alwin Krämer

12.6k total citations · 2 hit papers
124 papers, 5.9k citations indexed

About

Alwin Krämer is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Alwin Krämer has authored 124 papers receiving a total of 5.9k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Molecular Biology, 53 papers in Hematology and 42 papers in Oncology. Recurrent topics in Alwin Krämer's work include Acute Myeloid Leukemia Research (45 papers), Microtubule and mitosis dynamics (38 papers) and Cancer Diagnosis and Treatment (22 papers). Alwin Krämer is often cited by papers focused on Acute Myeloid Leukemia Research (45 papers), Microtubule and mitosis dynamics (38 papers) and Cancer Diagnosis and Treatment (22 papers). Alwin Krämer collaborates with scholars based in Germany, United States and Denmark. Alwin Krämer's co-authors include Jiří Bártek, Claudia Lukas, Frederic Tort, Zuzana Hořejšı́, Per Guldberg, Jiřina Bártková, Karsten Zieger, Torben F. Ørntoft, Karen Koed and Maxwell Sehested and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Alwin Krämer

119 papers receiving 5.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis

2005 2.1k citations Jiřina Bártková, Zuzana Hořejšı́ et al. Nature profile →
Tumour mutational burden: clinical utility, challenges and emerging improvements

2024 47 citations Jan Budczies, Daniel Kazdal et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alwin Krämer Germany	39	4.0k	2.2k	1.8k	835	814	124	5.9k
Mark Rolfe United States	31	4.6k 1.2×	2.5k 1.1×	1.2k 0.7×	471 0.6×	570 0.7×	55	6.0k
Joel Johansson United States	34	4.3k 1.1×	1.8k 0.8×	828 0.5×	1.1k 1.4×	512 0.6×	93	6.0k
Mohamed Rahmani United States	47	3.9k 1.0×	1.4k 0.6×	593 0.3×	1.2k 1.4×	554 0.7×	95	5.7k
Takehiko Kamijo Japan	37	5.1k 1.3×	3.2k 1.5×	574 0.3×	601 0.7×	1.0k 1.3×	114	7.1k
David J. Bearss United States	34	4.9k 1.2×	1.5k 0.7×	649 0.4×	457 0.5×	520 0.6×	114	6.5k
Markus Welcker United States	26	4.2k 1.1×	2.2k 1.0×	1.1k 0.6×	298 0.4×	626 0.8×	31	5.0k
John F. Lyons United States	32	2.7k 0.7×	1.3k 0.6×	475 0.3×	577 0.7×	551 0.7×	81	4.3k
Subrata Sen United States	41	5.5k 1.4×	3.4k 1.6×	3.8k 2.1×	277 0.3×	2.2k 2.7×	111	8.2k
Ada Sacchi Italy	55	5.8k 1.4×	3.7k 1.7×	1.2k 0.7×	286 0.3×	1.5k 1.8×	162	8.4k
Chen‐Yong Lin United States	38	2.5k 0.6×	765 0.4×	820 0.5×	967 1.2×	1.2k 1.5×	96	5.1k

Countries citing papers authored by Alwin Krämer

Since Specialization

Citations

This map shows the geographic impact of Alwin Krämer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alwin Krämer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alwin Krämer more than expected).

Fields of papers citing papers by Alwin Krämer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alwin Krämer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alwin Krämer. The network helps show where Alwin Krämer may publish in the future.

Co-authorship network of co-authors of Alwin Krämer

This figure shows the co-authorship network connecting the top 25 collaborators of Alwin Krämer. A scholar is included among the top collaborators of Alwin Krämer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alwin Krämer. Alwin Krämer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bochtler, Tilmann, Cornelia Coith, Harriet Wikman, et al.. (2024). Frequency and Prognostic Value of Circulating Tumor Cells in Cancer of Unknown Primary. Clinical Chemistry. 70(1). 297–306. 2 indexed citations

Dittrich, Tobias, Martin Schorb, Niels Weinhold, et al.. (2023). High-throughput electron tomography identifies centriole over-elongation as an early event in plasma cell disorders. Leukemia. 37(12). 2468–2478. 2 indexed citations

Tourneau, Christophe Le, Fabrice André, Åslaug Helland, et al.. (2023). Modified study designs to expand treatment options in personalised oncology: a multistakeholder view. European Journal of Cancer. 194. 113278–113278. 3 indexed citations

Regnery, Sebastian, et al.. (2023). Cancer of unknown primary (CUP) – lokal begrenzt, oligometastatisch und im Kopf-Hals-Bereich. Die Radiologie. 63(5). 358–365. 2 indexed citations

Dittrich, Tobias, et al.. (2023). Protocol for high-throughput electron tomography exemplified on centrioles in primary human plasma cells. STAR Protocols. 4(3). 102373–102373. 1 indexed citations

Bochtler, Tilmann, Thomas Hielscher, Damian Stichel, et al.. (2022). Prognostic impact of copy number alterations and tumor mutational burden in carcinoma of unknown primary. Genes Chromosomes and Cancer. 61(9). 551–560. 5 indexed citations

Breunig, Christian, Anja Baumann, Nicola Giesen, et al.. (2020). HDP-101, an Anti-BCMA Antibody–Drug Conjugate, Safely Delivers Amanitin to Induce Cell Death in Proliferating and Resting Multiple Myeloma Cells. Molecular Cancer Therapeutics. 20(2). 367–378. 61 indexed citations

Bochtler, Tilmann, Volker Endris, Thomas Hielscher, et al.. (2020). Integrated clinicomolecular characterization identifies RAS activation and CDKN2A deletion as independent adverse prognostic factors in cancer of unknown primary. International Journal of Cancer. 146(11). 3053–3064. 10 indexed citations

Bochtler, Tilmann, Volker Endris, Jonas Leichsenring, et al.. (2019). Comparative genetic profiling aids diagnosis and clinical decision making in challenging cases of CUP syndrome. International Journal of Cancer. 145(11). 2963–2973. 20 indexed citations

10.

Nagai, Tomoaki, Andrey Turchinovich, Natália Becker, et al.. (2016). Pharmacological Inhibition of Centrosome Clustering by Slingshot-Mediated Cofilin Activation and Actin Cortex Destabilization. Cancer Research. 76(22). 6690–6700. 23 indexed citations

11.

Bochtler, Tilmann, Stefan Fröhling, Wilko Weichert, et al.. (2016). Evolution of a FLT3-TKD mutated subclone at meningeal relapse in acute promyelocytic leukemia. Molecular Case Studies. 2(5). a001123–a001123. 2 indexed citations

12.

Bochtler, Tilmann, Friedrich Stölzel, Christoph E. Heilig, et al.. (2013). Clonal Heterogeneity As Detected by Metaphase Karyotyping Is an Indicator of Poor Prognosis in Acute Myeloid Leukemia. Journal of Clinical Oncology. 31(31). 3898–3905. 51 indexed citations

13.

Mardin, Balca R., et al.. (2013). EGF-Induced Centrosome Separation Promotes Mitotic Progression and Cell Survival. Developmental Cell. 25(3). 229–240. 57 indexed citations

14.

Raab, Marc S., Iris Breitkreutz, Simon Anderhub, et al.. (2012). GF-15, a Novel Inhibitor of Centrosomal Clustering, Suppresses Tumor Cell Growth In Vitro and In Vivo. Cancer Research. 72(20). 5374–5385. 56 indexed citations

15.

Löffler, H., Rainer Saffrich, Martin Mistrík, et al.. (2011). Cep63 Recruits Cdk1 to the Centrosome: Implications for Regulation of Mitotic Entry, Centrosome Amplification, and Genome Maintenance. Cancer Research. 71(6). 2129–2139. 47 indexed citations

16.

Sertel, Serkan, Yujie Fu, Yuangang Zu, et al.. (2011). Molecular docking and pharmacogenomics of Vinca alkaloids and their monomeric precursors, vindoline and catharanthine. Biochemical Pharmacology. 81(6). 723–735. 44 indexed citations

17.

Koledová, Zuzana, Alwin Krämer, Leona Rašková Kafková, & Vladimír Divoký. (2010). Cell-Cycle Regulation in Embryonic Stem Cells: Centrosomal Decisions on Self-Renewal. Stem Cells and Development. 19(11). 1663–1678. 20 indexed citations

18.

Shahmoradgoli, Maria, Felix B. Engel, Stefanie Heck, et al.. (2010). Antiapoptotic function of charged multivesicular body protein 5: A potentially relevant gene in acute myeloid leukemia. International Journal of Cancer. 128(12). 2865–2871. 14 indexed citations

19.

Larsen, Thomas Ostenfeld, Mads H. Clausen, Mads H. Rønnest, et al.. (2007). Identification of Griseofulvin as an Inhibitor of Centrosomal Clustering in a Phenotype-Based Screen. Cancer Research. 67(13). 6342–6350. 141 indexed citations

20.

Bártková, Jiřina, Zuzana Hořejšı́, Karen Koed, et al.. (2005). DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature. 434(7035). 864–870. 2117 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact